The human papillomavirus (HPV)

The human papillomavirus (HPV) is a group of more than 200 related viruses, most of which are sexually transmitted; some types of HPV cause warts (papillomas) on different parts of the body, while others cause cancer, especially in the cervix, anus, oropharynx and genitals HPV is one of the most common sexually transmitted infections (STIs) worldwide. 

Types of HPV :

 1. Low-risk HPV: - 

• Causes warts (e.g. genital warts and warts vulgaris). 
•  It does not cause cancer.  
• Examples: HPV types 6 and 11 (cause of most genital warts);

 2. High-risk HPV: - 

• Associated with the development of cancer.
• Persistent infection with these types can lead to precancerous changes and cancer. 
• Examples: e.g. HPV types 16 and 18 (cause of cervical cancer and most other HPV-related cancers).

 Symptoms of HPV 

1. Warts: - 

• Genital warts: soft, fleshy growths on the genitals, anus or around the mouth.
• Common warts: hard, raised bumps, usually on the hands or fingers. 
• Plantar warts: hard, granular growths on the soles of the feet. 
• Flat warts: slightly raised, smooth growths, usually on the face or feet; 

2. Pre-cancerous changes: -

•  detected by screening (e.g. Pap smear or HPV test). 
•  Found on the cervix, anus, pharynx, etc.

3. Symptoms of cancer (advanced stages): - 

• abnormal bleeding or discharge (e.g. vaginal bleeding). 
• Pain during sexual intercourse or urination. 
• Persistent sore throat or hoarseness (cancer of the middle pharynx). 
• Lumps or swelling in the affected area. 

Transmission

• Infection HPV is spread through direct skin-to-skin contact, such as  Vaginal, anal or oral sex. 
•  Close contact with infected skin or mucous membranes. 
•  Rarely, HPV can be transmitted from mother to baby during birth, even if the infected person has no visible signs or symptoms.

 Diagnosis :

1.For warts: - 

• Visual examination by a health professional.

2. For Cervical HPV infection: - 

• Pap smear: detects abnormal cervical cells.
• HPV test: confirms the presence of high-risk HPV. 
• Colposcopy: examines abnormal areas using a special microscope.

3. For other HPV-related disease: - 

• Biopsy of suspicious lesions or warts. 
•  Imaging studies of HPV-related cancers. 

 Treatment :

There is no treatment for HPV itself, but its symptoms and complications can be addressed: -

•  Topical treatment: salicylic acid, podophyllin or imiquimod. 
• Cryotherapy: freezing the warts with liquid nitrogen.
•  Surgical excision or laser treatment for stubborn warts;

 2. Precancerous changes: -

•  procedures such as cryotherapy, loop electrosurgical excision (LEEP) and conical excision to remove abnormal cells.

3.Cancer: -

•  Treatment depends on the type and stage of cancer and may include surgery, radiotherapy, chemotherapy and immunotherapy. 

 Prevention :

1. Vaccination: -

HPV vaccine (Gardasil 9): - 

• Protects against the most common cancer-causing HPV types (types 16 and 18) and the types that cause genital warts (types 6 and 11). 
•  Recommended for :
•        boys and girls aged 11-12 years (vaccination can be given from              age              9). 
•         Catch-up vaccination up to 26 years of age.
•         Some adults aged 27-45 years, after consultation with a health             professional.

2. Safe sexual practices: - 

• Use condoms or dental dams during sexual activity. 
•  Limit the number of sexual partners.

3. Regular check-ups: - 

•  Pap smear: Start at age 21 and continue as recommended in guidelines. 
•  HPV testing: For women over 30, usually combined with Pap smear.

4. Lifestyle measure: - 

• Avoid tobacco use as it increases the risk of HPV-related cancer. 
• Maintain a healthy immune system through a balanced diet and regular exercise. 

 Complications of HPV

 1. Genital warts: - 

• can recur even after treatment;

 Cancer: - 

• cervical cancer is the most common cancer associated with HPV.
•   Other affected sites include the anus, vulva, vagina, penis and oropharynx (throat and mouth).

3. Psychological outcomes: -

• Stigmatization and anxiety associated with the diagnosis. 
• Most HPV infections are cleared by the immune system within 1-2 years and do not cause problems.
• Persistent infection with high-risk HPV types can lead to precancerous changes and cancer if left untreated.
• Regular vaccination and screening can significantly reduce the burden of HPV-related disease.

Stem Cell Breakthrough for Cancer Patients

Recent advancements in stem cell therapy have opened new avenues for treating cancer cases, especially those with blood cancers such as leukemia, carcinoma, and multiple myeloma. Here’s an overview of the latest breakthrough and its implications 

Key Developments:

1. Expanded Donor Pool:

• Haploidentical Transplantation: A significant advancement in stem cell transplantation is the increased use of haploidentical( half- matched) donors. This approach allows patients to receive stem cells from family members who are only partially matched, expanding the donor pool significantly.
• T- Cell Depletion: Advances in techniques like T- cell depletion help reduce the risk of graft- versus- host disease( GVHD), a common complication in stem cell transplants. This makes haploidentical transplants safer and more viable.

2.  Genetically Modified Stem Cells:

• Gene Editing: Using CRISPR and other gene- editing technologies, scientists can modify stem cells to enhance their ability to fight cancer or to be more compatible with the patient’s immune system. This includes engineering stem cells to produce immune cells that can target and destroy cancer cells more effectively.
• CAR- T Therapy: Chimeric Antigen Receptor( CAR) T- cell  remedy involves modifying T cells to target specific cancer cells. While traditionally separate from stem cell transplants, this approach is increasingly being combined with stem cell therapies to improve issues for patients with refractory or relapsed cancers.

3.  Safer Conditioning Regimens: 

• Reduced Intensity Conditioning (RIC): New conditioning regimens that are less toxic than traditional high- dose chemotherapy allow more cases, including older adults and those with comorbidities, to undergo stem cell transplants. This increases the overall pool of patients who can benefit from these treatments

4. Autologous Transplantation Enhancements:  

• Enhanced Mobilization: Improved methods for mobilizing stem cells from the patient’s own bone marrow ( autologous transplantation) have increased the success rates of these procedures. This includes the use of newer medicines and ways to harvest more stem cells with fewer side effects. 

Clinical Implications:

• Broader Access: These advancements mean that more patients can access life- saving stem cell transplants, even if they lack a completely matched donor or have conditions that previously made transplantation too risky. 
• Improved Outcomes: The combination of genetically modified stem cells and safer conditioning regimens results in higher survival rates and better quality of life post-transplant. 
• Targeted Therapy: The integration of CAR- T therapy with stem cell transplants offers a powerful one- two punch against certain types of blood cancers, potentially leading to long- term remissions or cures. 

Future Directions:

• Personalized Medicine: Ongoing research aims to tailor stem cell and gene therapies to individual patient profiles, maximizing efficacy and minimizing side effects.
• Expanded suggestions: Researchers are exploring the use of these advanced stem cell therapies for solid tumors and other non-cancerous conditions, broadening their potential impact on healthcare.